Q2 EPS Estimates for Acadia Healthcare Lowered by KeyCorp

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – KeyCorp lowered their Q2 2025 earnings per share (EPS) estimates for shares of Acadia Healthcare in a research note issued on Monday, January 6th. KeyCorp analyst M. Gillmor now expects that the company will post earnings per share of $0.85 for the quarter, down from their previous forecast of $1.00. KeyCorp currently has a “Overweight” rating and a $70.00 target price on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. KeyCorp also issued estimates for Acadia Healthcare’s Q3 2025 earnings at $0.92 EPS.

ACHC has been the subject of several other reports. Royal Bank of Canada cut their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday, November 18th. TD Cowen cut their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday. Barclays decreased their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a report on Friday, November 22nd. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a report on Tuesday, December 10th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the company from $45.00 to $75.00 in a report on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $70.22.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $45.12 on Wednesday. The company has a fifty day moving average price of $40.48 and a two-hundred day moving average price of $58.19. Acadia Healthcare has a one year low of $36.50 and a one year high of $87.77. The stock has a market cap of $4.19 billion, a P/E ratio of 14.79, a P/E/G ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.91 EPS.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently modified their holdings of ACHC. GAMMA Investing LLC raised its stake in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after purchasing an additional 241 shares in the last quarter. Commonwealth Equity Services LLC increased its holdings in shares of Acadia Healthcare by 3.5% during the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after purchasing an additional 257 shares during the period. Atria Investments Inc raised its position in shares of Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after buying an additional 308 shares in the last quarter. KBC Group NV boosted its stake in shares of Acadia Healthcare by 14.4% in the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after buying an additional 338 shares during the period. Finally, Tidal Investments LLC grew its position in Acadia Healthcare by 7.9% during the third quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after buying an additional 340 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.